Literature DB >> 1642400

Psychosocial aspects of melanoma.

M Gibertini1, D S Reintgen, W F Baile.   

Abstract

Seventy-five patients with melanoma were surveyed for recent history of major stress, coping styles, and psychiatric disturbance. Recurrence of disease was strongly related to biological variables (stage and Breslow depths) but not to psychological measures. Major life stress was not related to stage, Breslow, Clark level, or estimates of lymphocytic infiltration of tumor. Coping styles were paradoxically related to major life stress such that history of major stresses was associated with greater confrontation of the melanoma diagnosis, greater will to fight the disease, and less avoidance of its frightening aspects. Experience with fewer major life stresses was associated with a defeatist attitude characterized by an expectation of a poor prognosis and little control over outcomes. More than 50% of the sample had experienced at least one major life stress in the past 5 years. This figure is consistent with prior work and indicative of a higher than normal rate of major life stress in the years before diagnosis.

Entities:  

Mesh:

Year:  1992        PMID: 1642400     DOI: 10.1097/00000637-199201000-00007

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.

Authors:  Mbathio Dieng; Nadine A Kasparian; Anne E Cust; Daniel S J Costa; Anh Tran; Phyllis N Butow; Scott W Menzies; Graham J Mann; Rachael L Morton
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

2.  [Psychosocial counseling of skin cancer patients in these times of diagnosis related groups (DRG)].

Authors:  G Strittmatter
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

3.  Willingness to pay for a cure of low-risk melanoma patients in Germany.

Authors:  Matthias Augustin; Christine Blome; Andrea Forschner; Ralf Gutzmer; Axel Hauschild; Lucie Heinzerling; Elisabeth Livingstone; Carmen Loquai; Dirk Schadendorf; Jochen Utikal; Tobias Wagner; Sophia Wilden; Katharina C Kähler
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.